uniQure N.V. Banner Image

uniQure N.V.

  • Ticker QURE
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
uniQure N.V. Logo Image
  • 201-500 Employees
  • Based in Amsterdam, Netherlands
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. They are leveraging their modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with hemophilia B, Huntington's disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases.
4.8 / 5.0 (146)

uniQure N.V. reports have an aggregate usefulness score of 4.8 based on 146 reviews.

uniQure N.V.

Most Recent Annual Report

uniQure N.V.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

uniQure N.V. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!